This program integrates the most advanced knowledge in Clinical Hepatology and gastroenterology, and will allow you to delve into the latest developments in the cardiomyopathy of the cirrhotic"

The increasing complexity of hepatology and gastroenterology has brought with it a great advance in diagnostic methods, treatments and surgical interventions in these fields. Thus, these disciplines have now integrated numerous highly effective solutions for pathologies that are difficult to treat, making it necessary for specialists to update their knowledge immediately.

For this reason, this program has been designed to incorporate all the innovations in this medical area, providing the professional with a complete update. Thus, throughout this Advanced master’s degree, it will be possible to learn about the latest developments in issues such as risk factors and screening for hepatocellular carcinoma, clinical manifestations and prognostic models of liver cirrhosis, non-cirrhotic portal hypertension or the role of the gastrointestinal tract in pediatric oncohematology.

All of this is based on an online learning system especially designed for working professionals, as it will adapt to the personal circumstances of the doctor, allowing them to study when and where they wish, without rigid schedules or uncomfortable travel. It will also have the latest content presented through different multimedia formats and will receive the support and guidance of a teaching staff made up of leading experts in these disciplines.

You will enjoy the best multimedia resources to get you up to speed quickly: video procedures, case studies, interactive summaries..."

This Advanced master’s degree in Clinical Hepatology contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of case studies presented by experts in medicine
• The graphic, schematic, and eminently practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies in hepatology and gastroenterology
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Access to content from any fixed or portable device with an Internet connection

Update your knowledge in hepatology in a quick and easy way thanks to the online methodology this Advanced master’s degree, which will allow you to combine your studies with your work without being subject to rigid schedules"

Its teaching staff includes professionals belonging to the field of medicine, who bring to this program the experience of their work, in addition to recognized specialists from prestigious reference societies and universities.

This program is designed around Problem-Based Learning, whereby the student must try to solve the different professional practical situations that arise during the academic year. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts 

Learn, thanks to this program, the latest developments in acute and chronic rejection in liver transplantation"

A teaching staff of great prestige in the field of hepatology will accompany you throughout the learning process"

This program has been designed by leading specialists in hepatology and gastroenterology, who have structured it into 19 specialized modules. Thus, through this itinerary, the physician will be able to learn about the most recent advances in aspects such as portal venous thrombosis in patients with cirrhosis, surgical risk assessment in cirrhotic patients, advances in the pathophysiology of pediatric inflammatory bowel disease or epigenetics and pediatric gastroenterology, among others.

There is no other program as complete and up to date as this one which is solely focused on the specialist in Clinical Hepatology"

Module 1. Diagnostic Methods and Research Techniques

1.1. Introduction to Diagnostic Methods Hepatic Function and Prognoses
1.2. Hepatic Biopsy
1.3. Non-invasive methods for Assessing Hepatic Fibrosis
1.4. Diagnostic Imaging: Ultrasound, CT, MRI
1.5. Basic and Advanced Endoscopy
1.6. Introduction to Research Techniques in Hepatology
1.7. Animal and Cellular Models
1.8. Immunological Techniques
1.9. PCR Techniques: Conventional and Point of Diagnosis
1.10. Next-Generation Sequencing Techniques: NGS

Module 2. Viral Hepatitis 

2.1. Hepatitis A
2.2. Hepatitis B (Epi, Natural Hº and Diagnosis)
2.3. Hepatitis B (Treatment)
2.4. Hepatitis B (Special Populations)
2.5. Hepatitis D
2.6. Hepatitis C (Epi, Natural Hº and Diagnosis)
2.7. Hepatitis C (Treatment)
2.8. Hepatitis C (Special Populations)
2.9. Hepatitis E
2.10. Other Viral Hepatitis

Módulo 3. Hepatitis y colangitis autoinmunes

3.1. HAI (Pathogenesis and Diagnostic Criteria)
3.2. HAI (Treatment)
3.3. HAI (Treatment in Non-Responders or Intolerant Patients)
3.4. HAI vs DILI: Immune-Mediated Hepatitis
3.5. Intrahepatic and Extrahepatic Cholestasis: Differential Dx
3.6. Primary Biliary Cholangitis (PBC): Pathogenesis and Dx 
3.7. PBC: Treatment
3.8. Primary Sclerosing Cholangitis (PSC): Pathogenesis, Symptoms and Diagnosis
3.9. CEP (Treatment)
3.10. Overlap Syndromes

Module 4. Alcoholic Liver Disease and Metabolic Hepatic Steatosis

4.1. Alcoholic Liver Disease (ALD): Epi, Clinical Manifestations and Natural Hº
4.2. ALD: Diagnosis and Severity Assessment
4.3. Acute Hepatitis
4.4. Cirrhosis
4.5. Liver Transplantation in ALD
4.6. Metabolic Hepatic Steatosis (MetHSS): Definition, Epi and Natural History
4.7. MetHSS: Pathogenesis and Role of the Intestinal Microbiota
4.8. MetHSS: Diagnosis
4.9. METHss: Treatment
4.10. Liver Cancer and Transplantation in MetHSS

Module 5. Hepatic Cirrhosis I

5.1. Definition, Pathophysiology, Natural History
5.2. Clinical Manifestations and Prognostic Models
5.3. Compensated and Decompensated Cirrhosis
5.4. Use of Medication in Cirrhotic Patients
5.5. Nutrition in Cirrhosis
5.6. Portal Hypertension
5.7. Ascites
5.8. Renal Failure in Cirrhosis: Classification, Diagnosis and Biomarkers
5.9. Treatment of Renal Insufficiency and Hepatorenal Syndrome 
5.10. The Role of Albumin in the Treatment of Cirrhotic Patients

Module 6. Hepatic Cirrhosis II  

6.1. Upper Gastrointestinal Bleeding (UGH) Secondary to Portal Hypertension 
6.2. TIPS: Current Indications
6.3. Hepatic Encephalopathy (HE): Concept, Pathogenesis and Symptoms. Minimum HE
6.4. HE: Treatment
6.5. Pulmonary Pathology in Cirrhosis: Hepatopulmonary Syndrome
6.6. Pulmonary Pathology in Cirrhosis: Porto-Pulmonary Hypertension
6.7. Acute on Chronic Hepatic Failure
6.8. Cardiomyopathy of the Cirrhotic Patient
6.9. Spontaneous Bacterial Peritonitis
6.10. Other Infections in the Cirrhotic Patient

Module 7. Other Metabolic Liver Diseases

7.1. Hemochromatosis: Epi and Clinical Manifestations
7.2. Hemochromatosis: Dx and Treatment
7.3. Hemochromatosis Due to Non-Classical Genes
7.4. Liver Porphyrias
7.5. Wilson's Disease: Epi and Clinical Manifestations
7.6. Wilson’s Disease: Diagnosis
7.7. Wilson Disease: Treatment 
7.8. Deficiency of Alfa1 Antitrypsin
7.9. LPAC
7.10. Glycogenosis

Module 8. Liver Tumors 

8.1. Epidemiology, Risk Factors, and Screening for Hepatocellular Carcinoma 
8.2. Diagnosis, Prognostic Evaluation and Staging of HCC
8.3. Hepatic Resection of HCC
8.4. Ablative HCC Treatments
8.5. Transarterial HCC Treatments
8.6. Liver Transplantation and HCC
8.7. Systemic HCC Treatment Basic Concepts, Immunotherapy, and Antiangiogenesis
8.8. Future Perspectives in HCC Management
8.9. Cholangicarcinoma
8.10. Benign Hepatic Tumors

Module 9. Liver Transplant

9.1. Indications, Patient Selection, and Waiting List Management
9.2. Expansion of Liver Transplant Criteria. Organ Preservation Strategies
9.3. Severe Acute Liver Failure
9.4. Liver Transplant Surgery
9.5. Infections and Liver Transplantation
9.6. Immunosuppression in Liver Transplantation. Acute and Chronic Rejection
9.7. Biliary Complications
9.8. Long-Term Management of Transplanted Patients
9.9. Hepatocarcinoma and De Novo Tumors After Liver Transplantation
9.10. Survival in Liver Transplantation. Factors Associated with Early and Late Mortality

Module 10. Miscellaneous: Hepatic Vascular Diseases, Hepatotoxicity, Hepatic Pathology in Pregnancy

10.1. Non-cirrhotic Portal Hypertension
10.2. Budd-Chiari Syndrome
10.3. Portal Venous Thrombosis in the Patient with Cirrhosis
10.4. Portal Venous Thrombosis in the Patient without Cirrhosis
10.5. Sinusoidal Obstruction Syndrome
10.6. DILI
10.7. Surgical Risk Assessment in the Cirrhotic Patient
10.8. Fontan-associated Liver Disease
10.9. Hepatic Pathology in Pregnancy (I)
10.10. Hepatic Pathology in Pregnancy (II)

Module 11. Advances in Food Allergy and Eosinophilic Disorders

11.1. Update on the Pathophysiological Basis of Food Allergy
11.2. Epidemiological Review of Food Allergy Clinical Presentations
11.3. Clinical Manifestations of Food Allergy and Intolerance
11.4. Diagnosis of Food Allergy A Constantly Evolving Challenge
11.5. Treatment of Food Allergy Current Outlook
11.6. Prevention of Food Allergy Current and Future Approach
11.7. Primary Eosinophilic Gastrointestinal Disorders Current Situation
11.8. In-depth Analysis of the Food Protein Induced Enterocolitis Syndrome (SEIPA– FPIES)
11.9. Diagnosis and Treatment of Eosinophilic Esophagitis and Eosinophilic Gastritis

Module 12. Update on Functional Digestive Disorders

12.1. Functional Digestive Disorders: Neurogastroenterology
12.2. Pathophysiology of Functional Digestive Disorders
12.3. The Intestinal Ecosystem in Functional Digestive Disorders
12.4. Multicultural Aspects of Functional Digestive Disorders
12.5. Biopsychosocial Aspects of Functional Digestive Disorders
12.6. Functional Digestive Disorders in Neonates and Infants
12.7. Functional Digestive Disorders in Children and Adolescents
12.8. Diagnostic Studies of Functional Digestive Disorders in Pediatric Ages 
12.9. Pharmacology, Pharmacokinetics and Pharmacogenomics Applied to Functional Digestive Disorders

Module 13. New Perspectives in Celiac Disease

13.1. Advances in the Pathophysiology of Celiac Disease
13.2. Current Epidemiology of Celiac Disease
13.3. Digestive and Extradigestive Clinical Manifestations Associated Diseases. 
Complications of Celiac Disease
13.4. Non-Celiac Gluten Sensitivity
13.5. Diagnosis of Celiac Disease Current Situation and Future Steps
13.6. New Laboratory Tests in Celiac Disease
13.7. Celiac Disease Treatment and Prevention
13.8. Food, Diet and Nutrition for Celiac Disease
13.9. Future Therapeutic Strategies

Module 14. Inflammatory Bowel Disease. Present and Future

14.1. Advances in the Pathophysiology of Pediatric inflammatory Bowel Disease
14.2. Diagnostic Criteria of Pediatric Inflammatory Bowel Disease
14.3. Diagnostic Tests of Pediatric Inflammatory Bowel Disease
14.4. Biological Markers of Activity and Prognosis
14.5. Pediatric Inflammatory Bowel Disease Activity Indices
14.6. Treatment of IBD Pharmacological Treatment. Biological Therapy and Biosimilars
14.7. Nutritional Treatment. Probiotics
14.8. Management of Treatment Algorithms in Ulcerative Colitis and Crohn's Disease
14.9. Management of Perianal Disease and Reservoritis
14.10. Complications of Pediatric Inflammatory Bowel Disease
14.11. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease and 
IBD-Associated Morbidity
14.12. Psychosocial Aspects of Pediatric Inflammatory Bowel Disease Transition Consultation

Module 15. Challenges in Esophageal and Gastric Pathology

15.1. Congenital Esophagogastric Anomalies
15.2. New Approaches to Gastroesophageal Reflux and Esophagitis in Pediatrics
15.3. Achalasia and Other Esophageal Motility Disorders
15.4. Trauma, Infections and Esophagitis Due to Chemicals
15.5. Review of Barrett's Esophagus in Pediatric Age
15.6. Peptic Ulcer Disease and Gastritis
15.7. Other Esophago-Gastric Pathologies
15.8. Use of Diagnostic Methods in Esophageal and Gastric Pathologies in Pediatric Ages 
15.9. Emergencies in Esophago-Gastric Pathology

Module 16. Update in Intestinal Pathology

16.1. Congenital Intestinal Anomalies
16.2. Disturbances of Digestion and Absorption
16.3. Intestinal Motility Disorders
16.4. Hirschsprung's Disease Intestinal Dysplasias
16.5. Viral and Bacterial Intestinal Infections
16.6. Intestinal Infections due to Parasites
16.7. Fungal Intestinal Infections
16.8. Neonatal Necrotizing Enterocolitis
16.9. Short Bowel Syndrome
16.10. Intestinal Polyps
16.11. Gastrointestinal Manifestations of Systemic Diseases
16.12. Digestive Complications of Congenital Heart Disease
16.13. Extraintestinal Manifestations of Digestive Diseases
16.14. Enteropathies of Unknown Origin Other Enteropathies
16.15. Intestinal Transplant
16.16. Emergencies in Intestinal Pathology

Module 17. Progress in Digestive and Hepatic Oncology

17.1. The Gastrointestinal Tract in Pediatric Oncohematology
17.2. Pediatric Gastrointestinal Neoplasms I (Esophagus to Duodenum)
17.3. Pediatric Gastrointestinal Neoplasms II (Jejunum to Anus)
17.4. Hepatic Tumors in Pediatrics
17.5. Primary Peritoneal Tumors and Peritoneal Carcinomatosis in Children
17.6. Gastrointestinal Complications of Chemotherapy in Children
17.7. Oncologic Abdominal Emergencies
17.8. Gastrointestinal Opportunistic Infections
17.9. Palliative Care for Children with Digestive Tumors

Module 18. Techniques in Pediatric Gastroenterology

18.1. Nutritional Assessment
18.2. Biochemical Determinations in Blood, Urine, Feces and Sweat
18.3. Digestive Endoscopy. Esophago-Gastroscopy and Colonoscopy in Pediatrics
18.4. Biopsies
18.5. Exhaled Air Test
18.6. Capsuloendoscopy in Pediatrics
18.7. Endoscopic Retrograde Cholangiopancreatography
18.8. Malabsorption and Pancreatic Insufficiency Studies
18.9. Gastrointestinal Tract Radiology
18.10. Gastrointestinal and Hepatobiliary Ultrasound
18.11. Endorectal Ultrasound in Pediatrics
18.12. Abdominal Computed Tomography and MRI in Pediatric Gastroenterology
18.13. Radioisotope Studies
18.14. Anorectal and Esophageal Manometry
18.15. Esophageal pH-Metry and Impedance Esophagometry
18.16. Microbiological Studies.
18.17. Molecular Biology Techniques
18.18. Exploratory laparoscopy

Module 19. Gastrohepatology: New Paths Opening the Door to Innovation

19.1. Chronobiology and Digestive Physiopathology
19.2. Epigenetics and Pediatric Gastroenterology
19.3. The Role of the Intestinal Microbiota in Children's Health and Disease
19.4. Study of the Intestinal Microbiota Probiotic Therapy in Pediatrics
19.5. Diet and Microbiota Impact on Health
19.6. Obesity and Digestive System Molecular, Genetic and Microbiological Approach to a Current Epidemic
19.7. Advances in Diagnostic Instruments Narrow-band Endoscopy Fluorescence Endoscopy Chromoendoscopy, Confocal Endoscopy and 360º Vision
19.8. Telemedicine Applications in the Education and Monitoring of Patients With Digestive Pathologies Wearables
19.9. Social Media and Pediatric Gastroenterology

In this program you will have access to the best contents, transmitted by a teaching staff of great international prestige"